ARDELYX, INC. — Director's Dealing 2015

Sep 3, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARDELYX, INC. (ARDX)
CIK: 0001437402
Period of Report: 2015-09-01

Reporting Person: Rosenbaum David P. (SVP, Drug Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-09-01	Common Stock	S	1286	$18.32	Disposed	0	Indirect
2015-09-03	Common Stock	S	1251	$19.25	Disposed	25880	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	77592	Indirect

Footnotes

F1: Consists of 1,286 shares acquired under the Issuer's Employee Stock Purchase Plan on August 31, 2015.

F2: The shares are directly held by the reporting person's wife.

F3: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 18, 2015.

F4: Consists of 1,251 shares acquired under the Issuer's Employee Stock Purchase Plan on August 31, 2015.

F5: The reporting person no longer has a reportable beneficial interest in 2,777 shares of the Issuer's common stock owned by his son and 2,777 shares of the Issuer's common stock owned by each of his two daughters, which shares were included in the reporting person's prior ownership reports.

F6: The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.